DNA and Gene Chip Market Size, Share & Growth Report | 2031
DNA and Gene Chip Market Size, Share & Growth Report | 2031
Segments - DNA and Gene Chip Market by Application (Genotyping, Drug Discovery, Gene Expression, Genomics, Cancer Diagnosis & Treatment, and Others), Product (Instrumentation and Consumables), End-user (Hospitals & Diagnostics Centers, Academic & Government Research Institutes, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-6132
| 4.6 Rating
| 54 Reviews
| 191 Pages
| Format :
Report Description
DNA and Gene Chip Market Outlook 2031
The global DNA and gene chip market size was USD 7 Billion in 2022 and is likely to reach USD 14 Billion by 2031, expanding at a CAGR of 11.8% during 2023–2031. The market growth is attributed to the increasing demand for early cancer detection across the globe.
High demand for early cancer detection is expected to boost the DNA and gene chip market in the coming years. Cancer is an extensive class of conditions that develop in practically any tissue or organ of the body when abnormal cells grow uncontrolled, cross normal cell boundaries to invade organs, and spread to other parts of the body. DNA and gene chips are used to determine the genetic & epigenetic landscape, measure gene expression patterns, and measure genomic regulatory elements bound to cancer transcription factors in cancer cells.
-
According to the American Cancer Society (ACS) in 2023, there are estimated to be 1,958,310 new cancer cases and 609,820 cancer deaths in the US.
The market report finds that the COVID-19 pandemic hindered the DNA and gene chip market, due to the strict lockdown imposed by the government. Several academic research centers and academic & government research institutes were temporarily shut down during the pandemic that affected the market. However, nucleic acid analysis was extremely effective for the primary detection of SARS-CoV during the pandemic. A major benefit of implementing a gene chip-based approach is that multi-target analysis possible in a simple test, which concludes to high throughput, high specificity, and sensitivity, which positively impacted the market.
DNA and Gene Chip Market Dynamics
Major Drivers
Rising technological advancements in DNA microarrays is expected to drive the DNA and gene chip market during the forecast period. Technological advancements in robotics, computational capabilities, and fabrication methods have led to the prompt uptake of gene chips in clinical laboratories across the globe. Microarrays are a powerful method for measurement of the gene expression, mutation detection, and bacterial/viral species identification. The microarray capability of parallel and high-throughput monitoring of biomolecules leads to the development of identifying applications for molecular diagnostics such as important applications in medical research, drug resistance, and pharmacogenomics. Fabrication techniques available in the market, including spotting, nano stamping, photolithography, and the latest processes for effective surface functionalization, aimed at reliable and proper microarray printing.
-
In November 2023, Lucid Diagnostics Inc. launched its next generation of the EsoGuard Esophageal DNA test (EsoGuard 2.0) for the detection of esophageal precancers, with enhanced assay performance and low costs. All commercial and research samples received by the laboratory are processed by using the EsoGuard 2.0 assay.
Increasing demand for personalized diagnosis and cancer treatment is anticipated to fuel the DNA and gene chip market in the coming years. There is a high demand for personalized medicines that are tailored to the genetic profile of individual patients, due to the increasing understanding of the genetic basis of diseases.
-
In September 2023, Illumina, Inc. collaborated with 54gene to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics, and clinical programs. This partnership supports the establishment of a new genetics facility in Lagos, Nigeria that is equipped with a suite of the cutting-edge sequencing and high-density microarray technology platforms by Illumina, Inc. This is expected to generate genetic information for health research and drug development.
Existing Restraints
Increasing demand for next generation sequencing (NGS) hinders the DNA and gene chip market. NGS is not yet able to completely replace microarrays in cytogenetics and diagnostics, owing to the relatively high price and stagnant rate of clinical implementation. However, strict regulatory scenarios and entry barriers for start-up companies hamper the DNA and chip market.
Emerging Opportunities
Increasing collaborations and strategic partnerships among companies is expected to create lucrative opportunities for the market players. Several companies are partnering and collaborating to develop new technologies that boost the market. Advances in DNA microarrays have resulted in the expansion of their application in biomedicine applications. Vendors are partnering in the development of new solutions for the analysis of microarray-generated data to simplify biomedicine applications of array technology.
-
In June 2022, Avesthagen Limited entered into a four-year strategic alliance with Wipro Limited to make its genetic testing portfolio commercial. The portfolio includes genome panels that offer highly specific and disease-centric analysis for conditions, including neurodegenerative diseases, cancers, autoimmune disorders, and rare disease conditions.
Scope of DNA and Gene Chip Market Report
The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
DNA and Gene Chip Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Application (Genotyping, Drug Discovery, Gene Expression, Genomics, Cancer Diagnosis & Treatment, and Others), Product (Instrumentation and Consumables), and End-user (Hospitals & Diagnostics Centers, Academic & Government Research Institutes, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Agilent Technologies, Inc; Arryait Corporation (ARYC); Eurofins Scientific; Illumina, Inc.; Macrogen, Inc.; Microarrays Inc; PerkinElmer Inc.; Savyon Diagnostics; Sysmex Corporation; Thermo Fisher Scientific Inc; and Twist Bioscience. |
DNA and Gene Chip Market Segment Insights
Application Segment Analysis
Based on application, the DNA and gene chip market is divided into genotyping, drug discovery, gene expression, genomics, cancer diagnosis & treatment, and others. The cancer diagnosis & treatment segment is expected to expand at a significant pace during the projection period, due to the high demand for targeted cancer therapies. Genetic chips offer an enhanced picture of a patient's cancer genomic profile, which helps the selection of appropriate cancer therapy.
The drug discovery segment is anticipated to hold a key share of the market in the coming years, owing to the rising adoption of genomic chip arrays for optimization of various aspects of traditional drug discovery processes. Gene chip arrays are used by pharmaceutical companies to improve nearly every aspect of the traditional drug discovery and development process, including target identification, target validation, compound screening, lead optimization, and clinical trials.
Product Segment Analysis
In terms of product, the global market is segregated into instrumentation and consumables. The consumable segment is projected to register a considerable CAGR during the forecast period, due to the increasing technological developments in gene expression analysis algorithms. The segment growth is further attributed to the easy availability of reagents and other ancillary components that are required for employing a microarray procedure.
End-user Segment Analysis
On the basis of end-user, the DNA and gene chip market is segmented into hospitals & diagnostics centers, academic & government research institutes, and others. The academic & government research institutes segment is expected to register a robust growth rate during the forecast period, due to the high acceptance of DNA microarrays by researchers to conduct their research projects. Academic researchers are partnering with scientists to discover the power of gene chips. Additionally, several academic researchers associated with the Human Genome Initiative actively follow the development of alternative types of DNA microarrays, particularly spotted and ink-jet microarrays, as competing systems to the gene chip.
Regional Analysis
In terms of region, the global DNA and gene chip market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the increasing presence of well-established key players and the presence of expert & skilled workforce in the region. The regional market growth is further attributed to the increasing advanced informatics infrastructure and ongoing genomic research & development practices in North America.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, owing to the rising investment in the research & development sector. The regional market growth is further attributed to the increasing awareness of genetic tests for disease risk assessment and prevention in the region.
Segments
The global DNA and gene chip market has been segmented on the basis of
Application
- Genotyping
- Drug Discovery
- Gene Expression
- Genomics
- Cancer Diagnosis & Treatment
- Others
Product
- Instrumentation
- Consumables
End-user
- Hospitals & Diagnostics Centers
- Academic & Government Research Institutes
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Agilent Technologies, Inc
- Arryait Corporation (ARYC)
- Eurofins Scientific
- Illumina, Inc.
- Macrogen, Inc.
- Microarrays Inc
- PerkinElmer Inc.
- Savyon Diagnostics
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Twist Bioscience.
Competitive Landscape
Key players competing in the global DNA and gene chip market are Agilent Technologies, Inc; Arryait Corporation (ARYC); Eurofins Scientific; Illumina, Inc.; Macrogen, Inc.; Microarrays Inc; PerkinElmer Inc.; Savyon Diagnostics; Sysmex Corporation; Thermo Fisher Scientific Inc.; and Twist Bioscience.
These key players adopt various strategies including mergers, acquisitions, collaboration, partnerships, product launches, and production expansion to expand their consumer base globally.
-
In November 2023, Twist Bioscience Corporation launched Twist Express Genes, a new gene synthesis service with an order-to-shipping turnaround time of five to seven business days. Twist Express Genes is the first new offering of the company, enabled by the increased capacity and streamlined process of the Wilsonville facility. The facility delivers the same NGS-verified clonally perfect genes in about half the time and at an unprecedented scale.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. DNA and Gene Chip Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DNA and Gene Chip Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DNA and Gene Chip Market - Supply Chain
4.5. Global DNA and Gene Chip Market Forecast
4.5.1. DNA and Gene Chip Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DNA and Gene Chip Market Size (000’ Units) and Y-o-Y Growth
4.5.3. DNA and Gene Chip Market Absolute $ Opportunity
5. Global DNA and Gene Chip Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. DNA and Gene Chip Market Size and Volume Forecast by Applications
5.3.1. Genotyping
5.3.2. Drug Discovery
5.3.3. Gene Expression
5.3.4. Genomics
5.3.5. Cancer Diagnosis & Treatment
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global DNA and Gene Chip Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. DNA and Gene Chip Market Size and Volume Forecast by End Users
6.3.1. Hospitals & Diagnostics Centers
6.3.2. Academic & Government Research Institutes
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global DNA and Gene Chip Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. DNA and Gene Chip Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global DNA and Gene Chip Demand Share Forecast, 2019-2026
8. North America DNA and Gene Chip Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America DNA and Gene Chip Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America DNA and Gene Chip Market Size and Volume Forecast by Applications
8.4.1. Genotyping
8.4.2. Drug Discovery
8.4.3. Gene Expression
8.4.4. Genomics
8.4.5. Cancer Diagnosis & Treatment
8.4.6. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America DNA and Gene Chip Market Size and Volume Forecast by End Users
8.7.1. Hospitals & Diagnostics Centers
8.7.2. Academic & Government Research Institutes
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America DNA and Gene Chip Demand Share Forecast, 2019-2026
9. Latin America DNA and Gene Chip Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America DNA and Gene Chip Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America DNA and Gene Chip Market Size and Volume Forecast by Applications
9.4.1. Genotyping
9.4.2. Drug Discovery
9.4.3. Gene Expression
9.4.4. Genomics
9.4.5. Cancer Diagnosis & Treatment
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America DNA and Gene Chip Market Size and Volume Forecast by End Users
9.7.1. Hospitals & Diagnostics Centers
9.7.2. Academic & Government Research Institutes
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America DNA and Gene Chip Demand Share Forecast, 2019-2026
10. Europe DNA and Gene Chip Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe DNA and Gene Chip Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe DNA and Gene Chip Market Size and Volume Forecast by Applications
10.4.1. Genotyping
10.4.2. Drug Discovery
10.4.3. Gene Expression
10.4.4. Genomics
10.4.5. Cancer Diagnosis & Treatment
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe DNA and Gene Chip Market Size and Volume Forecast by End Users
10.7.1. Hospitals & Diagnostics Centers
10.7.2. Academic & Government Research Institutes
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe DNA and Gene Chip Demand Share Forecast, 2019-2026
11. Asia Pacific DNA and Gene Chip Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific DNA and Gene Chip Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific DNA and Gene Chip Market Size and Volume Forecast by Applications
11.4.1. Genotyping
11.4.2. Drug Discovery
11.4.3. Gene Expression
11.4.4. Genomics
11.4.5. Cancer Diagnosis & Treatment
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific DNA and Gene Chip Market Size and Volume Forecast by End Users
11.7.1. Hospitals & Diagnostics Centers
11.7.2. Academic & Government Research Institutes
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific DNA and Gene Chip Demand Share Forecast, 2019-2026
12. Middle East & Africa DNA and Gene Chip Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa DNA and Gene Chip Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa DNA and Gene Chip Market Size and Volume Forecast by Applications
12.4.1. Genotyping
12.4.2. Drug Discovery
12.4.3. Gene Expression
12.4.4. Genomics
12.4.5. Cancer Diagnosis & Treatment
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa DNA and Gene Chip Market Size and Volume Forecast by End Users
12.7.1. Hospitals & Diagnostics Centers
12.7.2. Academic & Government Research Institutes
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa DNA and Gene Chip Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global DNA and Gene Chip Market: Market Share Analysis
13.2. DNA and Gene Chip Distributors and Customers
13.3. DNA and Gene Chip Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Agilent Technologies, Inc
13.4.2. Arryait Corporation (ARYC)
13.4.3. Eurofins Scientific
13.4.4. Illumina, Inc.
13.4.5. Macrogen, Inc.
13.4.6. Microarrays Inc
13.4.7. PerkinElmer Inc.
13.4.8. Savyon Diagnostics
13.4.9. Sysmex Corporation
13.4.10. Thermo Fisher Scientific Inc.
13.4.11. Twist Bioscience.
Methodology
Related Reports
Some other reports from this category!
Our Clients
